Genmab reported DKK1.97B in Sales Revenues for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Alexion Pharmaceuticals ALXN:US $ 1636.5M 44.7M
Amarin AMRN:US $ 154.49M 12.32M
Amgen AMGN:US $ 6526M 625M
AstraZeneca AZN:LN 8220M 900M
Bayer BAYN:GR € 10854M 1474M
Biomarin Pharmaceutical BMRN:US $ 501.69M 15.66M
Bluebird Bio BLUE:US $ 7.47M 5.32M
Exelixis EXEL:US $ 385.18M 114.95M
Fresenius Medical Care FME:GR € 4320M 110M
Galapagos GLPG:NA € 153.07M 28.91M
Genmab GEN:DC DK 1972M 391M
GlaxoSmithKline GSK:LN 8092M 674M
GN Store Nord GN:DC DK 3778M 332M
GRIFOLS GRF:SM € 1351.9M 167.16M
H. Lundbeck A/S LUN:DC 3.96B 313M
Hikma Pharmaceutical HIK:LN 1.22B 7M
Immunogen IMGN:US $ 16.95M 1.24M
Insmed INSM:US $ 45.37M 5.15M
Lonza Group LONN:SW 2.54B 1.11B
Merck MRK:GR € 4870M 239M
Novartis NOVN:VX SF 13294M 600M
Regeneron Pharmaceuticals REGN:US $ 5138.5M 2609.8M
Seattle Genetics SGEN:US $ 388.48M 56.5M
William Demant Holding WDH:DC 9.01B 621M